Skip to main content

Volume 17 Supplement 1

The Evidence Base of Frequently prescribed drugs in older Patients: A series of systematic reviews as a basis for recommendations in the PRIMA-eDS-tool to reduce inappropriate polypharmacy

Research

Publication of this supplement has not been supported by sponsorship. Information about the source of funding for publication charges can be found in the individual articles. The articles have undergone the journal's standard peer review process for supplements. The Supplement Editors declare that they have no competing interests.

Edited by Andreas Sönnichsen, Harm Van Marwijk and Gabriele Meyer

  1. Multimorbidity and polypharmacy are common in older people. Assessment tools or lists of criteria aimed at supporting prescription decisions for older people exist, but have often been based on expert opinion ...

    Authors: Yolanda V. Martinez, Anna Renom-Guiteras, David Reeves, R. Erandie Ediriweera de Silva, Aneez Esmail, Ilkka Kunnamo, Anja Rieckert, Christina Sommerauer and Andreas Sönnichsen
    Citation: BMC Geriatrics 2017 17(Suppl 1):231
  2. Preventable drug-related hospital admissions can be associated with drugs used in diabetes and the benefits of strict diabetes control may not outweigh the risks, especially in older populations. The aim of th...

    Authors: Gisela Schott, Yolanda V Martinez, R. Erandie Ediriweera de Silva, Anna Renom-Guiteras, Anna Vögele, David Reeves, Ilkka Kunnamo, Minna Marttila-Vaara and Andreas Sönnichsen
    Citation: BMC Geriatrics 2017 17(Suppl 1):226
  3. Platelet aggregation inhibitors (PAI) are among the most frequently prescribed drugs in older people, though evidence about risks and benefits of their use in older adults is scarce. The objectives of this sys...

    Authors: Maren Meinshausen, Anja Rieckert, Anna Renom-Guiteras, Moritz Kröger, Christina Sommerauer, Ilkka Kunnamo, Yolanda V. Martinez, Aneez Esmail and Andreas Sönnichsen
    Citation: BMC Geriatrics 2017 17(Suppl 1):225
  4. Oral anticoagulants are used for stroke prevention in patients with atrial fibrillation, the most common cardiac arrhythmia in older adults. The aim of our study was to identify the evidence on the risks and b...

    Authors: Christina Sommerauer, Lisa Schlender, Mark Krause, Sabine Weißbach, Anja Rieckert, Yolanda V Martinez, David Reeves, Anna Renom-Guiteras, Ilkka Kunnamo and Andreas Sönnichsen
    Citation: BMC Geriatrics 2017 17(Suppl 1):223

    The Correction to this article has been published in BMC Geriatrics 2018 18:12

  5. Metformin is usually prescribed as first line therapy for type 2 diabetes mellitus (DM2). However, the benefits and risks of metformin may be different for older people. This systematic review examined the ava...

    Authors: Lisa Schlender, Yolanda V. Martinez, Charles Adeniji, David Reeves, Barbara Faller, Christina Sommerauer, Thekraiat Al Qur’an, Adrine Woodham, Ilkka Kunnamo, Andreas Sönnichsen and Anna Renom-Guiteras
    Citation: BMC Geriatrics 2017 17(Suppl 1):227
  6. The benefit from a blood pressure lowering therapy with beta blockers may not outweigh its risks, especially in older populations. The aim of this study was to look for evidence on risks and benefits of beta bloc...

    Authors: Anna Vögele, Tim Johansson, Anna Renom-Guiteras, David Reeves, Anja Rieckert, Lisa Schlender, Anne-Lisa Teichmann, Andreas Sönnichsen and Yolanda V Martinez
    Citation: BMC Geriatrics 2017 17(Suppl 1):224
  7. Thiazides are commonly prescribed to older people for the management of hypertension. The objective of this study was to identify the evidence on the risks and benefits of their use among adults aged ≥65 years...

    Authors: Christina Sommerauer, Neha Kaushik, Adrine Woodham, Anna Renom-Guiteras, Yolanda V Martinez, David Reeves, Ilkka Kunnamo, Thekraiat Al Qur‵an, Steffen Hübner and Andreas Sönnichsen
    Citation: BMC Geriatrics 2017 17(Suppl 1):228

Annual Journal Metrics

  • 2022 Citation Impact
    4.1 - 2-year Impact Factor
    4.9 - 5-year Impact Factor
    1.546 - SNIP (Source Normalized Impact per Paper)
    1.127 - SJR (SCImago Journal Rank)

    2023 Speed
    61 days submission to first editorial decision for all manuscripts (Median)
    194 days submission to accept (Median)

    2023 Usage 
    5,279,671 downloads
    4,306 Altmetric mentions 

Sign up for article alerts and news from this journal